Suppr超能文献

艾滋病患者中由肠微孢子虫引起的播散性微孢子虫病:临床特征及对阿苯达唑治疗的反应

Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy.

作者信息

Molina J M, Oksenhendler E, Beauvais B, Sarfati C, Jaccard A, Derouin F, Modaï J

机构信息

Division of Infectious Diseases, Hôpital Saint-Louis, Paris, France.

出版信息

J Infect Dis. 1995 Jan;171(1):245-9. doi: 10.1093/infdis/171.1.245.

Abstract

Five patients with AIDS had disseminated infection due to Septata intestinalis, a recently described organism. S. intestinalis infection was suspected after detection of spores in stools and urine and confirmed by transmission electron microscopy of duodenal biopsies or of cell culture of urine sediment. Clinical features included chronic diarrhea that was usually associated with fever, cholangitis, sinusitis, bronchitis, or mild bilateral conjunctivitis. Mean CD4 cell count was 22/microL. Patients treated with albendazole (400 mg orally twice a day) for a mean of 19 days had a dramatic and rapid clinical response to therapy. Significant reduction of parasite shedding was also observed during therapy; S. intestinalis was cleared from stools of all patients and from urine of 3. In 2 patients, however, microsporidian spores were detected in feces during follow-up and mild diarrhea recurred. Therefore, albendazole seems to have a significant but transient effect in treatment of S. intestinalis infection.

摘要

5例艾滋病患者发生了由肠道Septata菌(一种最近才被描述的微生物)引起的播散性感染。在粪便和尿液中检测到孢子后怀疑存在肠道Septata菌感染,并通过十二指肠活检的透射电子显微镜检查或尿沉渣的细胞培养得以确诊。临床特征包括通常伴有发热的慢性腹泻、胆管炎、鼻窦炎、支气管炎或轻度双侧结膜炎。平均CD4细胞计数为22/μL。接受阿苯达唑(每日口服两次,每次400mg)治疗平均19天的患者对治疗有显著且迅速的临床反应。治疗期间还观察到寄生虫排出显著减少;所有患者的粪便中以及3例患者的尿液中的肠道Septata菌均被清除。然而,在2例患者的随访期间粪便中检测到微孢子虫孢子,并且再次出现轻度腹泻。因此,阿苯达唑在治疗肠道Septata菌感染方面似乎具有显著但短暂的效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验